These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification of der(1;19)(q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss. Griffin CA, Burger P, Morsberger L, Yonescu R, Swierczynski S, Weingart JD, Murphy KM. J Neuropathol Exp Neurol; 2006 Oct; 65(10):988-94. PubMed ID: 17021403 [Abstract] [Full Text] [Related]
3. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. Smith JS, Perry A, Borell TJ, Lee HK, O'Fallon J, Hosek SM, Kimmel D, Yates A, Burger PC, Scheithauer BW, Jenkins RB. J Clin Oncol; 2000 Feb; 18(3):636-45. PubMed ID: 10653879 [Abstract] [Full Text] [Related]
5. A new der(1;7)(q10;p10) leading to a singular 1p loss in a case of glioblastoma with oligodendroglioma component. Gadji M, Crous-Tsanaclis AM, Mathieu D, Mai S, Fortin D, Drouin R. Neuropathology; 2014 Apr; 34(2):170-8. PubMed ID: 24118308 [Abstract] [Full Text] [Related]
7. Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics. Perry A, Fuller CE, Banerjee R, Brat DJ, Scheithauer BW. Front Biosci; 2003 Jan 01; 8():a1-9. PubMed ID: 12456321 [Abstract] [Full Text] [Related]
8. Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade. Iwadate Y, Matsutani T, Hara A, Hirono S, Ikegami S, Kobayashi M, Ito D, Kawauchi D, Horiguchi K, Tamiya A, Higuchi Y. J Neurooncol; 2019 Jan 01; 141(1):205-211. PubMed ID: 30565028 [Abstract] [Full Text] [Related]
9. Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival. Felsberg J, Erkwoh A, Sabel MC, Kirsch L, Fimmers R, Blaschke B, Schlegel U, Schramm J, Wiestler OD, Reifenberger G. Brain Pathol; 2004 Apr 01; 14(2):121-30. PubMed ID: 15193024 [Abstract] [Full Text] [Related]
10. Evaluation of chromosome 1p/19q deletion by Fluorescence in Situ Hybridization (FISH) as prognostic factors in malignant glioma patients on treatment with alkylating chemotherapy. Pandith AA, Zahoor W, Manzoor U, Nisar S, Guru FR, Naikoo NA, Aein QU, Baba SM, Bhat AR, Ganai F, Shah P. Cancer Genet; 2023 Nov 01; 278-279():55-61. PubMed ID: 37625215 [Abstract] [Full Text] [Related]
11. Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study. Brandes AA, Tosoni A, Cavallo G, Reni M, Franceschi E, Bonaldi L, Bertorelle R, Gardiman M, Ghimenton C, Iuzzolino P, Pession A, Blatt V, Ermani M, GICNO. J Clin Oncol; 2006 Oct 10; 24(29):4746-53. PubMed ID: 16954518 [Abstract] [Full Text] [Related]
16. Is the 1p/19q deletion a diagnostic marker of oligodendrogliomas? Gadji M, Fortin D, Tsanaclis AM, Drouin R. Cancer Genet Cytogenet; 2009 Oct 10; 194(1):12-22. PubMed ID: 19737649 [Abstract] [Full Text] [Related]
17. Contribution of 1p, 19q, 9p and 10q Automated Analysis by FISH to the Diagnosis and Prognosis of Oligodendroglial Tumors According to WHO 2016 Guidelines. Michaud K, de Tayrac M, D'Astous M, Duval C, Paquet C, Samassekou O, Gould PV, Saikali S. PLoS One; 2016 Oct 10; 11(12):e0168728. PubMed ID: 28030632 [Abstract] [Full Text] [Related]
18. High Carbonic Anhydrase-9 Expression Identifies a Subset of 1p/19q Co-Deletion and Favorable Prognosis in Oligodendroglioma. Sathornsumetee S, Cheunsuchon P, Sangruchi T. World Neurosurg; 2016 Jul 10; 91():518-523.e1. PubMed ID: 26960282 [Abstract] [Full Text] [Related]
19. 1p/19q co-deleted fibrillary astrocytomas: Not everything that is co-deleted is an oligodendroglioma. Andrews C, Prayson RA. Ann Diagn Pathol; 2020 Jun 10; 46():151519. PubMed ID: 32305004 [Abstract] [Full Text] [Related]